BiotechTube

Abametapir Lotion 0.74% w/w + Vehicle Lotion

Phase 3Completed
0 watching 0 views this week📈 Rising
74
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Head Lice Infestation

Conditions

Head Lice Infestation

Trial Timeline

Feb 1, 2014 → Aug 1, 2014

NCT ID
NCT02060903

About Abametapir Lotion 0.74% w/w + Vehicle Lotion

Abametapir Lotion 0.74% w/w + Vehicle Lotion is a phase 3 stage product being developed by Dr. Reddy's Laboratories for Head Lice Infestation. The current trial status is completed. This product is registered under clinical trial identifier NCT02060903. Target conditions include Head Lice Infestation.

Hype Score Breakdown

Clinical
27
Activity
18
Company
7
Novelty
9
Community
10

Clinical Trials (3)

NCT IDPhaseStatus
NCT02097485Phase 2Completed
NCT02060903Phase 3Completed
NCT02062060Phase 3Completed

Competing Products

20 competing products in Head Lice Infestation

See all competitors
ProductCompanyStageHype Score
AFM24 + SNK01AffimedPhase 1/2
33
Cemiplimab + CetuximabEli LillyPhase 2
52
BB-401Benitec BiopharmaPhase 2
44
Placebo + LY2300559Eli LillyPhase 2
52
Gemcitabine + ACR-368Acrivon TherapeuticsPhase 2
44
Ketorolac + Prochlorperazine + DiphenhydramineAssertio HoldingsPhase 2
44
Ramucirumab + PembrolizumabEli LillyPhase 2
52
Ozuriftamab Vedotin + Pembrolizumab + Evalstotug (BA3071) + CetuximabBioAtlaPhase 2
44
Patritumab + Cetuximab + Cisplatin + Carboplatin + PlaceboDaiichi SankyoPhase 2
52
Patritumab + Cetuximab + Cisplatin + CarboplatinDaiichi SankyoPhase 1
33
cevimeline hydrochlorideDaiichi SankyoPhase 3
77
Docetaxel + Erlotinib + ChemotherapyAstellas PharmaPhase 2
52
ErlotinibAstellas PharmaPhase 1
33
avelumab + Bempegaldesleukin + talazoparib + enzalutamideAstellas PharmaPhase 1/2
41
Ivermectin Lotion, 0.5% + SKLICE (ivermectin) Lotion, 0.5% + Vehicle of the Test productSun PharmaceuticalPhase 1
33
Drug Combination TherapySun PharmaceuticalPhase 2
52
Lenvatinib + Pembrolizumab + Docetaxel + Capecitabine + Paclitaxel + Cetuximab + LenvatinibEisaiPhase 2
52
E7050 + CetuximabEisaiPhase 1/2
41
Lenvatinib + Pembrolizumab + PlaceboEisaiPhase 3
77
Lenvatinib + Pembrolizumab + PlaceboEisaiPhase 3
77

Other Products from Dr. Reddy's Laboratories

OMEZ 40 + OMEZ 80Approved
82
Ketorolac Tromethamine + KetoprofenApproved
82
omeprazole+domperidone SR + omeprazoleApproved
82
NISEApproved
82
Levofloxacin + LevofloxacinApproved
82